Cardio-Renal-Metabolic Breakthroughs: What Nephrologists Must Know Now

This episode explores the game-changing role of diabetes medications in preventing heart failure and improving outcomes across cardiovascular, metabolic, and kidney systems. We review a meta-analysis on semaglutide, new insights on SGLT2 inhibitors, and the evolving concept of Cardiovascular-Kidney-Metabolic (CKM) syndrome — all with a focus on what this means for nephrology practice.